WallStreetZenWallStreetZen

NASDAQ: LXRX
Lexicon Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LXRX past revenue growth

How has LXRX's revenue growth performed historically?
Company
766.19%
Industry
148.4%
Market
16.96%
LXRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LXRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LXRX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LXRX earnings and revenue history

Current Revenue
$1.2M
Current Earnings
-$177.1M
Current Profit Margin
-14,710.9%

LXRX Return on Equity

Current Company
-139.7%
Current Industry
-63.5%
Current Market
188%
LXRX's Return on Equity (-139.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LXRX announces earnings.

LXRX Return on Assets

Current Company
-71.9%
Current Industry
2.9%
LXRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LXRX Return on Capital Employed

Current Company
-82.89%
Current Industry
19.5%
LXRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LXRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LXRX$1.20M-$163.46M-$177.12M-54.71%N/A
ADCT$69.56M-$151.36M-$240.05M+127.56%N/A
TRML$0.00-$41.97M-$42.12MN/AN/A
MREO$10.00M-$27.34M-$29.47M-53.16%N/A
HRTX$127.04M-$107.16M-$110.56M+10.40%N/A
View Top Biotech Stocks

LXRX earnings dates

Next earnings date
Apr 30, 2024

Lexicon Pharmaceuticals Earnings & Revenue FAQ

What were LXRX's earnings last quarter?

On Invalid Date, Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q4 2023 earnings per share (EPS) of -$0.20, up 17.65% year over year. Total Lexicon Pharmaceuticals earnings for the quarter were -$49.76 million. In the same quarter last year, Lexicon Pharmaceuticals's earnings per share (EPS) was -$0.17.

If you're new to stock investing, here's how to buy Lexicon Pharmaceuticals stock.

What was LXRX's earnings growth in the past year?

As of Q2 2024, Lexicon Pharmaceuticals's earnings has grown year over year. Lexicon Pharmaceuticals's earnings in the past year totalled -$177.12 million.

What is LXRX's earnings date?

Lexicon Pharmaceuticals's earnings date is Invalid Date. Add LXRX to your watchlist to be reminded of LXRX's next earnings announcement.

What was LXRX's revenue last quarter?

On Invalid Date, Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q4 2023 revenue of $702.00 thousand up 2,407.14% year over year. In the same quarter last year, Lexicon Pharmaceuticals's revenue was $28.00 thousand.

What was LXRX's revenue growth in the past year?

As of Q2 2024, Lexicon Pharmaceuticals's revenue has grown 766.19% year over year. This is 617.78 percentage points higher than the US Biotechnology industry revenue growth rate of 148.4%. Lexicon Pharmaceuticals's revenue in the past year totalled $1.20 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.